Phase II study combining an anti-core 1 O-glycans targeting humanized monoclonal antibody NEO-201 with pembrolizumab in adults with chemo-resistant solid tumors
Mark-Adjeli, Princess, Cole, Christopher Browning, McCoy, Ann, Fantini, Massimo, Mavroukakis, Sharon, Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip Martin, Annunziata, Christina M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Phase I clinical trial of NEO-201, an anti-tumor-associated CEACAM-5/6 monoclonal antibody in solid tumors
Cole, Christopher Browning, Morelli, Maria Pia, Fantini, Massimo, Fergusson, Maria, Mavroukakis, Sharon A., Zaki, Anjum, Tsang, Kwong Y., Arlen, Philip Martin, Annunziata, Christina M.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article